| Name | Title | Contact Details |
|---|---|---|
Jeff Keyes |
Chief Financial Officer | Profile |
Claudia Drayton |
Chief Financial Officer | Profile |
Christine Nishiyama |
Vice President of Supply Chain and Reagent Manufacturing | Profile |
Alex Hutcheson |
Senior Vice President of Sales and Service | Profile |
Matt Dyer |
Chief Business Officer / Chief Product Officer | Profile |
Seattle Institute for Biomedical and Clinical Research is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AnaptysBio is a privately-held antibody development company focused on novel programs in immuno-oncology and inflammation. The Company`s first-in-class proprietary pipeline includes ANB020, an anti-IL-33 antibody for the treatment of severe adult asthma and peanut allergy, and ANB019, an anti-IL-36 receptor antibody for the treatment of generalized pustular psoriasis. AnaptysBio`s SHM-XEL platform has pioneered the use of in vitro somatic hypermutation for antibody discovery and optimization, which replicates key features of the human immune system and overcomes limitations of prior antibody technologies. AnaptysBio has previously announced partnerships with several biopharmaceutical companies, including Novartis, Gilead, Celgene, Momenta and TESARO.
Alfa Wassermann, Inc. is a West Caldwell, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Hawaii Chitopure is a Honolulu, HI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Human Genome Sciences, Inc. is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.